Skip to main content
. 2020 Mar 15;106(4):733–742. doi: 10.1016/j.ijrobp.2019.11.397

Table 3.

Incidence of pneumonitis, esophagitis, adverse events, and adverse events at least possibly related to radiation therapy

Toxicity and grade 6-week schedule
5-week schedule
Total
Group 1 (n = 35) Group 2 (n = 47) Group 1 (n = 12) Group 2 (n = 24) (n = 118)
Pneumonitis
 1 13 (37%) 11 (23%) 1 (8%) 4 (17%) 29 (25%)
 2 10 (29%) 12 (26%) 4 (33%) 4 (17%) 30 (25%)
 3 2 (6%) 1 (2%) 0 1 (4%) 4 (3%)
 4 0 0 0 0 0
 5 0 0 0 0 0
Esophagitis
 1 1 (3%) 4 (9%) 0 0 5 (4%)
 2 30 (86%) 33 (70%) 11 (92%) 22 (92%) 96 (81%)
 3 2 (6%) 3 (6%) 1 (8%) 1 (4%) 7 (6%)
 4 0 0 0 0 0
 5 0 0 0 0 0
Any adverse event
 1 0 0 0 0 0
 2 8 (23%) 10 (21%) 5 (42%) 6 (25%) 29 (25%)
 3 21 (60%) 26 (55%) 7 (58%) 18 (75%) 72 (61%)
 4 4 (11%) 9 (19%) 0 0 13 (11%)
 5 2 (6%) 2 (4%) 0 0 4 (3%)
Any adverse event at least possibly related to radiation therapy
 1 0 2 (4%) 0 0 2 (2%)
 2 17 (49%) 19 (40%) 8 (67%) 17 (71%) 61 (52%)
 3 13 (37%) 20 (43%) 4 (33%) 7 (29%) 44 (37%)
 4 3 (9%) 6 (13%) 0 0 9 (8%)
 5 2 (6%) 0 0 0 2 (2%)

The table summarizes the highest grades of pneumonitis, esophagitis, and adverse events experienced by each patient.

Of 120 patients recruited, 118 began treatment.